Bacterial strains and consortium comprising same for degrading mtbe, tba and/or hcho
AssigneeVito NV
InventorsLeen Bastiaens, Queenie Simons, Linde Debor, David Moreels
Life of this patent
Estimating the term…
Abstract
The present invention provides tools and methods for degrading MTBE, TBA and/or HCHO using abacterial consortium comprising one or more strains selected from Methylibium LD3, Hydrogenophaga LD1 and/or Mycobacterium LD6.
Claims17
An isolated bacterial consortium comprising Methylibium strain LD3 deposited as LMG P-27480, and characterized by the presence of the 16S rRNA sequence SEQ ID NO:1, which is a methyl-tertiary-butyl-ether (MTBE) degrading consortium.
(canceled)
A method for detecting the presence of one or a combination of a Methylibium LD3 micro-organism deposited as LMG P-27480, a Hydrogenophaga LD1 micro-organism deposited as LMG P-27479, and a Mycobacterium LD6 micro-organism deposited as LMG P-27498 in a sample comprising identifying the presence of a sequence corresponding to SEQ ID NO:1, SEQ ID NO:2 or SEQ ID NO:3, respectively in said sample optionally by contacting said sample with a primer or probe capable of hybridizing specifically to or amplifying a sequence specific for SEQ ID NO:1, SEQ ID NO:2 or SEQ ID NO:3 and determining the presence of a hybridization signal or an amplification product indicative of the presence of one or a combination of the Methylibium LD3 micro-organism deposited as LMG P-27480, the Hydrogenophaga LD1 micro-organism deposited as LMG P-27479, and the Mycobacterium LD6 micro-organism deposited as LMG P-27498 in the sample.
An isolated methyl-tertiary-butyl-ether (MTBE) degrading Methylibium strain, which is characterized by the presence of 16S RNA sequence SEQ ID NO:1 and is strain Methylibium LD3, deposited as LMG P-27480.
Dependencies are inferred from the claim text.